New clotting drug aims to stop dangerous bleeding in heart surgery

NCT ID NCT07094087

Recruiting now Disease control Sponsor: CSL Behring Source: ClinicalTrials.gov ↗

Summary

This study is testing an experimental medicine (BE1116) designed to help blood clot better during and after complex heart surgery that uses a heart-lung bypass machine. It will compare this medicine to the standard treatment, fresh frozen plasma, in 200 adults who start bleeding during their operation. The main goal is to see which treatment is better and safer at quickly correcting the patient's clotting problems and reducing bleeding.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COMPLEX CARDIOVASCULAR SURGERY WITH CARDIOPULMONARY BYPASS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hospital Civil de Guadalajara
NOT_YET_RECRUITING

Guadalajara, Jalisco, 44100, Mexico
Instituto Nacional de Cardiolgia Ignacio Chavez (National Institute of Cardiology)
NOT_YET_RECRUITING

Mexico City, Mexico City (cdmx), 14080, Mexico
Kingston Health Science Center
NOT_YET_RECRUITING

Kingston, Ontario, K7L 2V7, Canada
Kyushu University Hospital
RECRUITING

Fukuoka, Fukuoka, 812-8582, Japan
London Health Sciences Center - University Campus
RECRUITING

London, Ontario, N6A 5A5, Canada
National Cerebral and Cardiovascular Center
NOT_YET_RECRUITING

Suita, Osaka, 564-8565, Japan
North Shore University Hospital
NOT_YET_RECRUITING

Manhasset, New York, 11040, United States
OUHSC (University of Oklahoma Health Sciences Center)
NOT_YET_RECRUITING

Oklahoma City, Oklahoma, 73104, United States
Oregon Health & Sciences University
NOT_YET_RECRUITING

Portland, Oregon, 97239, United States
Sakakibara Heart Institute
NOT_YET_RECRUITING

Fuchu-shi, Tokyo, 183-0003, Japan
Thomas Jefferson University Hospital
RECRUITING

Philadelphia, Pennsylvania, 19107, United States
UCLA Health - Ronald Reagan Medical Center
NOT_YET_RECRUITING

Los Angeles, California, 90095, United States
UT Southwestern Medical Center
NOT_YET_RECRUITING

Dallas, Texas, 75390, United States
Universite de Montreal-Institut de Cardiologie de Montreal (ICM) Montreal Heart Institute (MHI)
NOT_YET_RECRUITING

Montreal, Quebec, H1T1C8, Canada
University of Chicago Medicine
NOT_YET_RECRUITING

Chicago, Illinois, 60637, United States
University of Cincinnati
RECRUITING

Cincinnati, Ohio, 45267, United States
University of Maryland Medical Center (UMMC)
NOT_YET_RECRUITING

Baltimore, Maryland, 21201, United States
University of Toronto - St. Michael's Hospital (SMH) - Keenan Research Centre for Biomedical Science
NOT_YET_RECRUITING

Toronto, Ontario, M5B 1W8, Canada
University of Virginia Health System
NOT_YET_RECRUITING

Charlottesville, Virginia, 22908, United States

Conditions

Explore the condition pages connected to this study.

COMPLEX CARDIOVASCULAR SURGERY WITH CARDIOPULMONARY BYPASS